Le Lézard
Classified in: Science and technology
Subject: IPO

AppLovin Announces Pricing of Initial Public Offering


AppLovin Corporation ("AppLovin"), a global technology platform that provides developers a unified set of tools to grow their business, today announced the pricing of its initial public offering of 25,000,000 shares of its Class A common stock at a price of $80.00 per share. AppLovin is offering 22,500,000 shares of its Class A common stock and KKR Denali Holdings L.P. is offering 2,500,000 shares of Class A common stock. In connection with the offering, the underwriters will have a 30-day option to purchase up to an additional 3,750,000 shares from KKR Denali Holdings L.P. AppLovin will not receive any proceeds from the sale of shares by KKR Denali Holdings L.P. AppLovin's Class A common stock is expected to begin trading on the Nasdaq Global Select Market on April 15, 2021 under the symbol "APP" and the offering is expected to close on April 19, 2021, subject to customary closing conditions.

A registration statement relating to the sale of these securities was declared effective by the Securities and Exchange Commission on April 14, 2021. Morgan Stanley, J.P. Morgan, KKR Capital Markets, LLC, BofA Securities and Citigroup are acting as lead book-running managers for the offering. Credit Suisse and UBS Investment Bank are acting as additional book-running managers for the offering. Blaylock Van, LLC, Guzman & Company, LionTree Advisors, LUMA Securities, Oppenheimer & Co., R. Seelaus & Co., LLC, The Raine Group, Roberts & Ryan, Stifel, Truist Securities, and William Blair are acting as co-managers for the offering. The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained by contacting: Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, or J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by telephone at 866-803-9204 or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About AppLovin

AppLovin's global technology platform provides developers a powerful, integrated set of solutions to grow their businesses. AppLovin enables developers to market, monetize, analyze and publish their apps. Its studios create popular, immersive content and its technology brings that content to users around the world. AppLovin is headquartered in Palo Alto, California with several offices globally.


These press releases may also interest you

at 18:50
The Honourable Jonathan Wilkinson, Minister of Energy and Natural Resources, along with Rebecca Bligh, Second Vice-President of the Federation of Canadian Municipalities (FCM) and Vancouver City Councillor, and Linda Buchanan, Mayor of the City of...

at 18:46
StoneCo Ltd. reported adjusted net income of R$ 450 million in the first quarter, a 90% increase over the same time last year. The company's total revenue reached R$ 3.1 billion, a 14% year-over-year growth. Adjusted net cash was R$ 5.1 billion,...

at 18:42
VC Include (VCI), an organization committed to evolving the traditional investment industry by creating an inclusive ecosystem of LPs and GPs from diverse backgrounds, today announced the cohort for this year's Fellowship for Impact Fund I...

at 18:30
Cannabix Technologies Inc. (the "Company or Cannabix") reports that it has entered into an arm's length marketing agreements with the following parties: Effective May 13, 2024, the Company has engaged Financial Buzz Media Networks LLC ("FBMN") for...

at 18:25
It is with great pleasure that we announce the Federal Commission for Protection against Health Risks (COFEPRIS) in Mexico has granted approval for oral, once-daily ORLADEYO® (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks...

at 17:59
Genifi inc. ("genifi" or the "Company") announced today that at the request of the Ontario Securities Commission it is providing certain additional background information in respect of the proposed privatization transaction described in the...



News published on and distributed by: